India to Australia: Esomeprazole Export Trade Route
India has recorded 409 verified shipments of Esomeprazole exported to Australia, representing a combined trade value of $29.5M USD. This corridor is served by 5 active Indian exporters, with an average shipment value of $72.1K USD. The leading Indian exporter is SUN PHARMACEUTICAL INDUSTRIES LIMITED, which accounts for 82% of total export value with 301 shipments worth $24.2M USD. On the buying side, M/S. SUN PHARMA ANZ PTY LTD is the largest importer in Australia with $14.8M USD in purchases. The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED , JUBILANT GENERICS LIMITED — together control 99% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to Australia Esomeprazole corridor is one of India's established pharmaceutical export routes, with 409 shipments documented worth a combined $29.5M USD. The route is dominated by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone accounts for roughly 82% of all export value, reflecting the consolidated nature of India's esomeprazole manufacturing sector.
Across 5 active suppliers, the average shipment value stands at $72.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 71% of all shipments, consistent with esomeprazole's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 24 days port-to-port. The route has recorded an annual growth rate of 34.1%, placing it at rank #10 among India's top esomeprazole export destinations globally.
On the import side, key buyers of Indian esomeprazole in Australia include M/S. SUN PHARMA ANZ PTY LTD, SUN PHARMA ANZ PTY LTD., SUN PHARMA ANZ PTY LTD and 14 others. M/S. SUN PHARMA ANZ PTY LTD is the single largest importer with 24 shipments valued at $14.8M USD.
Route Characteristics
- Average transit24 days
- Peak seasonQ4
- Primary modeSea freight
- Top portSTARTRACK TERMINAL ICD
Market Position
- Global rank#10
- Annual growth+34.1%
- Demand growth+29.8%
- Regulatory ease73/100
Top 10 Indian Esomeprazole Exporters to Australia
Showing top 10 of 5 Indian suppliers exporting Esomeprazole to Australia, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $80.4K per shipment | 301 | $24.2M | 82.1% |
| 2 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $55.2K per shipment | 87 | $4.8M | 16.3% |
| 3 | JUBILANT GENERICS LIMITED Avg $19.8K per shipment | 13 | $257.1K | 0.9% |
| 4 | JUBILANT GENERICS LIMITED Avg $27.3K per shipment | 7 | $190.8K | 0.6% |
| 5 | JUBILANT GENERICS LTD Avg $25.1K per shipment | 1 | $25.1K | 0.1% |
This table shows the top 10 of 5 Indian companies exporting esomeprazole to Australia, ranked by total trade value. The listed exporters are: SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED , JUBILANT GENERICS LIMITED , JUBILANT GENERICS LIMITED, JUBILANT GENERICS LTD. SUN PHARMACEUTICAL INDUSTRIES LIMITED is the dominant supplier with 301 shipments worth $24.2M USD, giving it a 82% market share. The top 3 suppliers together account for 99% of the total trade value on this route.
Top 10 Esomeprazole Importers in Australia
Showing top 10 of 17 known buyers in Australia receiving Esomeprazole shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian esomeprazole in Australia include M/S. SUN PHARMA ANZ PTY LTD, SUN PHARMA ANZ PTY LTD., SUN PHARMA ANZ PTY LTD, SUN PHARMA ANZ PTY LTD. , M/S. SUN PHARMA ANZ PTY LTD , among 17 total buyers. The largest importer is M/S. SUN PHARMA ANZ PTY LTD, accounting for $14.8M USD across 24 shipments — representing 50% of all esomeprazole imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | M/S. SUN PHARMA ANZ PTY LTD | 24 | $14.8M | 50.0% |
| 2 | SUN PHARMA ANZ PTY LTD. | 187 | $5.8M | 19.6% |
| 3 | SUN PHARMA ANZ PTY LTD | 47 | $2.2M | 7.4% |
| 4 | SUN PHARMA ANZ PTY LTD. | 32 | $2.1M | 7.1% |
| 5 | M/S. SUN PHARMA ANZ PTY LTD | 39 | $1.8M | 6.0% |
| 6 | SUN PHARMA ANZ PTY LIMITED | 40 | $1.4M | 4.6% |
| 7 | SUN PHARMA ANZ PTY LTD | 12 | $796.4K | 2.7% |
| 8 | SUN PHARMA ANZ PTY LTD., | 4 | $137.4K | 0.5% |
| 9 | GENERIC HEALTH C/O DHL SUPPLY CHAIN | 5 | $119.7K | 0.4% |
| 10 | Generic Health C/O DHL Supply Chain | 6 | $113.2K | 0.4% |
Showing top 10 of 17 Esomeprazole importers in Australia on this route.
Top 10 Esomeprazole Formulations Imported by Australia
Showing top 10 of 133 product formulations shipped on the India to Australia Esomeprazole route, ranked by trade value
Australia imports a wide range of esomeprazole formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — ESOMEPRAZOLE MAGNESIUM GASTRO RESISTANT — accounts for $15.5M USD across 31 shipments. There are 133 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ESOMEPRAZOLE MAGNESIUM GASTRO RESISTANT | 31 | $15.5M | 52.7% |
| 2 | ESOMEPRAZOLE MAGNESIUM GASTRO RESISTANT | 102 | $5.8M | 19.7% |
| 3 | ESOMEPRAZOLE MAGNESIUM GASTRO RESISTANTTABLETS 20 MG (APO-ESOMEPRAZOLE TAB 20MG(CFB) AUST) EACH GASTRORESISTANT TABLET | 26 | $1.2M | 4.0% |
| 4 | ESOMEPRAZOLE MAGNESIUM GASTRO RESISTANTTABLETS 20 MG (APO-ESOMEPRAZOLE TAB 20MG(CFB) AUST) EACH GASTRORESISTANT TABLETPCS | 25 | $649.3K | 2.2% |
| 5 | ESOMEPRAZOLE MAGNESIUM GASTRO RESISTANTTABLETS 40 MG (APO-ESOMEPRAZOLE TAB40MG(CFB) AUST) EACH GASTRORESISTANT TABLET | 10 | $403.6K | 1.4% |
| 6 | ESOMEPRAZOLE MAGNESIUM GASTRO RESISTANTTABLETS 20 MG (NEXOLE TAB 20MG 3X10B CFB) AUST) EACH GASTRORESISTANT TABLET CONT | 13 | $379.5K | 1.3% |
| 7 | ESOMEPRAZOLE MAGNESIUM GASTRO RESISTANTTABLETS 20 MG (GUARDIUM ACID RR TAB 20MG2X7B(CFB)AUST) EACH GASTRO-RESISTANT TA | 8 | $349.3K | 1.2% |
| 8 | ESOMEPRAZOLE MAGNESIUM GASTRO RESISTANTTABLETS 20 MG (CHEMIST O HBR ESOME TAB 20MG 2X7B(CFB)AUST) EACH GASTRO-RESISTANT | 5 | $200.1K | 0.7% |
| 9 | ESOMEPRAZOLE MAGNESIUM GASTRO RESISTANTTABLETS 20 MG (NEXOLE TAB 20MG 3X10B CFB) AUST) EACH GASTRORESISTANT TABLET CONTPCS | 12 | $172.0K | 0.6% |
| 10 | ESOMEPRAZOLE MAGNESIUM GASTRO RESISTANTTABLETS MG BATCH : PTG1114B PTG1198A PTG1199A & PTG1312A | 1 | $123.1K | 0.4% |
Showing top 10 of 133 Esomeprazole formulations imported by Australia on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 71%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
STARTRACK TERMINAL ICD handles the highest volume with 103 shipments. Transit time averages 24 days by sea.
Market Dynamics
India's esomeprazole exports to Australia are driven primarily by a handful of large-scale manufacturers. SUN PHARMACEUTICAL INDUSTRIES LIMITED with 301 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 5 active exporters signals a competitive but concentrated market — buyers in Australia benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED , JUBILANT GENERICS LIMITED — together account for 99% of total trade value on this route. The average shipment value of $72.1K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as esomeprazole magnesium gastro resistant and esomeprazole magnesium gastro resistanttablets 20 mg (apo-esomeprazole tab 20mg(cfb) aust) each gastroresistant tablet, suggesting that buyers in Australia tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, M/S. SUN PHARMA ANZ PTY LTD is the largest importer with 24 shipments worth $14.8M USD — representing 50% of all esomeprazole imports from India on this route. A total of 17 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $29.5M
- Avg. Shipment
- $72.1K
- Suppliers
- 5
- Buyers
- 17
- Transit (Sea)
- ~24 days
- Annual Growth
- +34.1%
Related Analysis
Reverse Direction
Australia → India — Esomeprazole (Import)Other Esomeprazole Routes
Unlock the Full India to Australia Esomeprazole Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 409 shipments on this route.
Frequently Asked Questions — India to Australia Esomeprazole Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Esomeprazole to Australia?
The leading Indian exporters of Esomeprazole to Australia are SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED , JUBILANT GENERICS LIMITED . SUN PHARMACEUTICAL INDUSTRIES LIMITED holds the largest market share at approximately 82% of total trade value on this route.
Q What is the total value of Esomeprazole exports from India to Australia?
India exports Esomeprazole to Australia worth approximately $29.5M USD across 409 recorded shipments. The average value per shipment is $72.1K USD.
Q Which ports does India use to ship Esomeprazole to Australia?
The most active port of origin is STARTRACK TERMINAL ICD with 103 shipments. Indian exporters primarily use sea freight for this route, with 71% of shipments going by sea and 20% by air.
Q How long does shipping take from India to Australia for Esomeprazole?
The average transit time for Esomeprazole shipments from India to Australia is approximately 24 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to Australia Esomeprazole trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 34.1% with demand growth tracking at 29.8%. The route is ranked #10 among India's top Esomeprazole export destinations globally.
Q How many suppliers are active on the India to Australia Esomeprazole route?
There are currently 5 active Indian suppliers exporting Esomeprazole to Australia. The market is moderately concentrated with SUN PHARMACEUTICAL INDUSTRIES LIMITED accounting for 82% of total shipment value.
Q Who are the main importers of Esomeprazole from India in Australia?
The leading importers of Indian Esomeprazole in Australia include M/S. SUN PHARMA ANZ PTY LTD, SUN PHARMA ANZ PTY LTD., SUN PHARMA ANZ PTY LTD, SUN PHARMA ANZ PTY LTD. , M/S. SUN PHARMA ANZ PTY LTD . M/S. SUN PHARMA ANZ PTY LTD is the largest buyer with 24 shipments worth $14.8M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Australia export trade corridor identified from Indian Customs (DGFT) records for Esomeprazole.
- 2.Supplier/Buyer Matching: 5 Indian exporters and 17 importers in Australia matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 409 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
409 Verified Shipments
5 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists